rs3735782

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_013964.5(NRG1):​c.*2937C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.417 in 151,942 control chromosomes in the GnomAD database, including 13,973 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 13973 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

NRG1
NM_013964.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.615

Publications

15 publications found
Variant links:
Genes affected
NRG1 (HGNC:7997): (neuregulin 1) The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]
NRG1 Gene-Disease associations (from GenCC):
  • schizophrenia 6
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_013964.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.486 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013964.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRG1
NM_013964.5
MANE Select
c.*2937C>A
3_prime_UTR
Exon 12 of 12NP_039258.1Q02297-1
NRG1
NM_001322205.2
c.*2937C>A
3_prime_UTR
Exon 9 of 9NP_001309134.1A0A494C0Q4
NRG1
NM_013956.5
c.*2937C>A
3_prime_UTR
Exon 13 of 13NP_039250.2Q02297-6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRG1
ENST00000405005.8
TSL:1 MANE Select
c.*2937C>A
3_prime_UTR
Exon 12 of 12ENSP00000384620.2Q02297-1
NRG1
ENST00000356819.7
TSL:1
c.*2937C>A
3_prime_UTR
Exon 12 of 12ENSP00000349275.6Q02297-7
NRG1
ENST00000652592.1
c.*2937C>A
3_prime_UTR
Exon 9 of 9ENSP00000498646.1A0A494C0Q4

Frequencies

GnomAD3 genomes
AF:
0.418
AC:
63403
AN:
151822
Hom.:
13973
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.262
Gnomad AMI
AF:
0.382
Gnomad AMR
AF:
0.481
Gnomad ASJ
AF:
0.535
Gnomad EAS
AF:
0.447
Gnomad SAS
AF:
0.502
Gnomad FIN
AF:
0.476
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.474
Gnomad OTH
AF:
0.452
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.417
AC:
63411
AN:
151942
Hom.:
13973
Cov.:
32
AF XY:
0.422
AC XY:
31339
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.261
AC:
10818
AN:
41424
American (AMR)
AF:
0.481
AC:
7342
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.535
AC:
1854
AN:
3468
East Asian (EAS)
AF:
0.448
AC:
2307
AN:
5150
South Asian (SAS)
AF:
0.502
AC:
2424
AN:
4826
European-Finnish (FIN)
AF:
0.476
AC:
5024
AN:
10546
Middle Eastern (MID)
AF:
0.462
AC:
134
AN:
290
European-Non Finnish (NFE)
AF:
0.474
AC:
32217
AN:
67956
Other (OTH)
AF:
0.448
AC:
944
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1829
3657
5486
7314
9143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.440
Hom.:
8998
Bravo
AF:
0.410
Asia WGS
AF:
0.456
AC:
1585
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
9.2
DANN
Benign
0.63
PhyloP100
0.61

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3735782;
hg19: chr8-32624857;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.